 Connection
Jennifer Oliver to Case-Control Studies
This is a "connection" page, showing publications Jennifer Oliver has written about Case-Control Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.092 |
|
|
|
-
Chatzilena A, Hyams C, Challen R, Marlow R, King J, McGuinness S, Maskell N, Oliver J, Finn A, Danon L. Winter 2022-23 influenza vaccine effectiveness against influenza-related hospitalised aLRTD: A test-negative, case-control study. Vaccine. 2024 Oct 03; 42(23):126073.
Score: 0.033
-
Chatzilena A, Hyams C, Challen R, Marlow R, King J, Adegbite D, Kinney J, Clout M, Maskell N, Oliver J, Finn A, Danon L. Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn-winter (bivalent vaccine) booster campaigns: a prospective test negative case-control study, United Kingdom, 2022. Euro Surveill. 2023 11; 28(48).
Score: 0.032
-
Hyams C, Marlow R, Maseko Z, King J, Ward L, Fox K, Heath R, Tuner A, Friedrich Z, Morrison L, Ruffino G, Antico R, Adegbite D, Szasz-Benczur Z, Garcia Gonzalez M, Oliver J, Danon L, Finn A. Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study. Lancet Infect Dis. 2021 11; 21(11):1539-1548.
Score: 0.027
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|